Current status: 857 hESC lines, 3298 hiPSC lines, and 100 clinical studies, and 442 certificates
Monthly statistic from Oct 1, 2022
Posted on October 1, 2022
| total lines | 4155 |
| hESC lines | 857 |
| hiPSC lines | 3298 |
| derivation countries | 43 |
| projects | 246 |
| providers | 751 |
| clinical studies | 100 |
| subclones | 1739 |
| certificates | 442 |
| cell line certificates | 313 |
| project certificates | 129 |